SCHEMBL55421

SCHEMBL55421

O=C(O)N1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27840293 1.00 CA12 (0.56)
Hydrochloric Acid SCHEMBL2686905 0.97 CA12 (0.54)
SCHEMBL1291157 0.90 MEN1 (0.58)
Formic Acid SCHEMBL18578706 0.90 SMN1; SMN2 (0.48)
SCHEMBL7962619 0.90 KMT2A (0.71)
SCHEMBL31758693 0.88 MEN1 (0.56)
SCHEMBL2678907 0.84 KMT2A (0.83)
SCHEMBL908027 0.83
Biphenyl SCHEMBL27551921 0.82 RAB9A (0.63)
Dioxane SCHEMBL28104333 0.81 MEN1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4453 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4192833-B1 PHARMACOLOGICALLY ACTIVE HETEROCYCLIC-SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES RICHTER GEDEON NYRT (HU) 2026-01-21 EP claimed
EP-4577528-A1 PREPARATION OF A P2X3 ANTAGONIST 14245563 Canada Inc. (CA) 2025-07-02 EP claimed
EP-3880678-B1 CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATE GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 3 LTD (GB) 2025-05-07 EP claimed
CN-119161627-A High-elasticity organic silicon aerogel and preparation method thereof 安徽斯迈特新材料股份有限公司 2024-12-20 CN claimed
EP-4008718-B1 HETEROARYLAMIDOPYRIDINOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE INNOVO THERAPEUTICS INC (KR) 2024-10-30 EP claimed
EP-3759113-B1 10-(DI(PHENYL)METHYL)-4-HYDROXY-8,9,9A,10-TETRAHYDRO-7H-PYRROLO[1',2':4,5]PYRAZINO[1,2-B]PYRIDAZINE-3,5-DIONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE ORTHOMYXOVIRUS REPLICATION FOR TREATING INFLUENZA NOVARTIS AG (CH) 2024-09-11 EP claimed
US-20240174715-A1 PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS INDI MOLECULAR, INC. 2024-05-30 US claimed
CN-117980310-A Alkylene derivatives as KRAS inhibitors 尼坎治疗公司 2024-05-03 CN claimed
US-11919972-B2 Peptide libraries with non-canonical amino acids REGENERON PHARMACEUTICALS, INC. (US) 2024-03-05 US claimed
WO-2024042471-A1 PREPARATION OF A P2X3 ANTAGONIST 14245563 CANADA INC. (CA) 2024-02-29 WO claimed
WO-1994027627-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-12-08 WO claimed
EP-0621788-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-11-02 EP claimed
EP-0229667-B1 Peptidylaminodiols ABBOTT LAB (US) 1994-07-13 EP claimed
EP-0604368-A1 Anti retroviral hydrazine derivatives CIBA-GEIGY AG (CH) 1994-06-29 EP claimed
EP-0593227-A1 Carbamates of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-20 EP claimed
EP-0584487-A2 4,5-Dihydro-4-oxopyrrolo (1,2-a) quinoxalines and aza-analoges and process for their preparation ASTA Medica Aktiengesellschaft (DE) 1994-03-02 EP claimed
CN-1077960-A HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1993-11-03 CN claimed
WO-1993013789-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1993-07-22 WO claimed
US-4845079-A HYPOTENSIVE, RENIN INHIBITION ABBOTT LABORATORIES 1989-07-04 US claimed
EP-0229667-A2 Peptidylaminodiols ABBOTT LABORATORIES (US) 1987-07-22 EP claimed